Development of Novel Strategy for Treatment of Anterior Cruciate Ligament (ACL) Injury Using Stem Cell

NCT02755376 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Deficiency of Anterior Cruciate Ligament

Interventions

BIOLOGICAL: Cartistem(TM)
BIOLOGICAL: hyaluronic acid
PROCEDURE: ACL reconstruction only

Sponsor

Samsung Medical Center